Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain
IntroductionChronic pelvic pain affects up to 24% of women worldwide and for up to 55% of these there is no associated pathology. Despite this there are no established treatments in this cohort. This is a secondary analysis of a randomised-controlled trial (GaPP2) to explore if there are measures wh...
Saved in:
| Main Authors: | Lydia Coxon, Maryam Amer, Jane Daniels, Ann M. Doust, Scott C. Mackenzie, Andrew W. Horne, Katy Vincent |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1460206/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perbandingan Dosis Induksi dan Pemeliharaan Propofol Pada Operasi Onkologi Mayor yang Mendapatkan Pemedikasi Gabapentin dan Tanpa Gabapentin
by: Ida Bagus Okta, et al.
Published: (2017-11-01) -
Assessment of community pharmacists’ experiences and perceptions on gabapentin abuse in Jordan: a cross-sectional study
by: Rana Abu-Farha, et al.
Published: (2024-12-01) -
Association of perioperative initiation of gabapentin versus pregabalin with kidney function: a target trial emulation study
by: Yanfang He, et al.
Published: (2024-12-01) -
Development of a Population Pharmacokinetic Gabapentin Model Leveraging Therapeutic Drug Monitoring Concentrations
by: Firas Al-Zubaydi, et al.
Published: (2024-11-01) -
Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety
by: Víctor Mayoral, et al.
Published: (2025-01-01)